Invention Grant
US08372970B2 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
失效
8-乙基-6-(芳基)吡啶并[2,3-D]嘧啶-7(8H) - 酮治疗中枢神经系统疾病
- Patent Title: 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
- Patent Title (中): 8-乙基-6-(芳基)吡啶并[2,3-D]嘧啶-7(8H) - 酮治疗中枢神经系统疾病
-
Application No.: US13500295Application Date: 2010-10-08
-
Publication No.: US08372970B2Publication Date: 2013-02-12
- Inventor: Benedikt Vollrath , David Campbell , Sergio G. Durón , Warren Wade
- Applicant: Benedikt Vollrath , David Campbell , Sergio G. Durón , Warren Wade
- Applicant Address: US CA La Jolla
- Assignee: Afraxis, Inc.
- Current Assignee: Afraxis, Inc.
- Current Assignee Address: US CA La Jolla
- Agency: Wilson, Sonsini, Goodrich & Rosati
- International Application: PCT/US2010/052106 WO 20101008
- International Announcement: WO2011/044535 WO 20110414
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D471/04 ; C07D401/14 ; C07D239/00
![8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders](/abs-image/US/2013/02/12/US08372970B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
Public/Granted literature
- US20120270866A1 8-ETHYL-6-(ARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS Public/Granted day:2012-10-25
Information query